Nexus AG has announced an increase in voting rights held by UBS Group AG, raising its stake from 4.98% to 5.09%. This change reflects UBS's strategic investment interests in Nexus AG, which operates in the healthcare sector, providing software and IT solutions for healthcare facilities. The company, based in Donaueschingen, Germany, is listed on multiple stock exchanges, including Frankfurt, Berlin, and Munich, and currently has a market cap of €1.18 billion.